Medical Research and Clinical Trials

AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening

• Medical Research and Clinical Trials

AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening

Ali Ikhwan August 11, 2026

URBANA-CHAMPAIGN, IL – The future of breast cancer screening is not a binary choice between human expertise...

Read More Read more about AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening

Moderna’s mFLUSIVA Revolutionizes Influenza Prevention with First Standalone mRNA Vaccine Approval

• Medical Research and Clinical Trials

Moderna’s mFLUSIVA Revolutionizes Influenza Prevention with First Standalone mRNA Vaccine Approval

Jia Lissa August 11, 2026

Boston, MA – [Insert Date] – In a landmark development poised to reshape the landscape of infectious...

Read More Read more about Moderna’s mFLUSIVA Revolutionizes Influenza Prevention with First Standalone mRNA Vaccine Approval

A New Trojan Horse: Mount Sinai Scientists Redefine Immunotherapy by Targeting Cancer’s Protectors

• Medical Research and Clinical Trials

A New Trojan Horse: Mount Sinai Scientists Redefine Immunotherapy by Targeting Cancer’s Protectors

Dwi Wanna August 11, 2026

NEW YORK, NY – In a significant paradigm shift for cancer treatment, scientists at the Icahn School...

Read More Read more about A New Trojan Horse: Mount Sinai Scientists Redefine Immunotherapy by Targeting Cancer’s Protectors

Akeso Pioneers Novel Combination Therapy for Advanced Breast Cancer, Integrating Cutting-Edge Immuno-Oncology and ADC Technologies

• Medical Research and Clinical Trials

Akeso Pioneers Novel Combination Therapy for Advanced Breast Cancer, Integrating Cutting-Edge Immuno-Oncology and ADC Technologies

Lina Hope August 11, 2026

Shanghai, China – [Insert Date] – In a significant stride towards revolutionizing cancer treatment, Akeso, a biopharmaceutical...

Read More Read more about Akeso Pioneers Novel Combination Therapy for Advanced Breast Cancer, Integrating Cutting-Edge Immuno-Oncology and ADC Technologies

Breakthrough Research: Prophylactic Oophorectomy Dramatically Boosts Survival for BRCA Breast Cancer Patients, Dispelling Long-Held Fears

• Medical Research and Clinical Trials

Breakthrough Research: Prophylactic Oophorectomy Dramatically Boosts Survival for BRCA Breast Cancer Patients, Dispelling Long-Held Fears

Jia Lissa August 10, 2026

Cambridge, UK – A groundbreaking study from the University of Cambridge has delivered profoundly reassuring news for...

Read More Read more about Breakthrough Research: Prophylactic Oophorectomy Dramatically Boosts Survival for BRCA Breast Cancer Patients, Dispelling Long-Held Fears

Urgent Push for Ervebo Against Bundibugyo Ebola Strain Amidst Vaccine Void

• Medical Research and Clinical Trials

Urgent Push for Ervebo Against Bundibugyo Ebola Strain Amidst Vaccine Void

Nana August 10, 2026

In a significant development for global public health, a pivotal meeting convened by the World Health Organization...

Read More Read more about Urgent Push for Ervebo Against Bundibugyo Ebola Strain Amidst Vaccine Void

Unlocking Colorectal Cancer’s Paradox: A Paradigm Shift in Immunotherapy Targeting

• Medical Research and Clinical Trials

Unlocking Colorectal Cancer’s Paradox: A Paradigm Shift in Immunotherapy Targeting

Dwi Wanna August 10, 2026

New Research Reveals Dual Nature of Immune Cells, Paving Way for Precision Treatments For decades, a perplexing...

Read More Read more about Unlocking Colorectal Cancer’s Paradox: A Paradigm Shift in Immunotherapy Targeting

Soligenix Pivots Strategy After HyBryte Fails Phase III, Focusing on Rare Disease and Novel Vaccine Technology

• Medical Research and Clinical Trials

Soligenix Pivots Strategy After HyBryte Fails Phase III, Focusing on Rare Disease and Novel Vaccine Technology

Nana Muazin August 10, 2026

[City, State] – [Date] – Soligenix, Inc., a clinical-stage biopharmaceutical company, has announced a significant strategic redirection...

Read More Read more about Soligenix Pivots Strategy After HyBryte Fails Phase III, Focusing on Rare Disease and Novel Vaccine Technology

Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

• Medical Research and Clinical Trials

Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Ali Ikhwan August 10, 2026

LA JOLLA, CA – May 12, 2025 – In a landmark study that could redefine the treatment...

Read More Read more about Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Cambridge Breakthrough: Revolutionary Treatment Achieves 100% Survival in Aggressive Inherited Breast Cancer

• Medical Research and Clinical Trials

Cambridge Breakthrough: Revolutionary Treatment Achieves 100% Survival in Aggressive Inherited Breast Cancer

Azzam Bilal Chamdy August 10, 2026

Cambridge, UK – [Date of Publication] – A groundbreaking new treatment approach, pioneered by researchers at Cambridge,...

Read More Read more about Cambridge Breakthrough: Revolutionary Treatment Achieves 100% Survival in Aggressive Inherited Breast Cancer